Correction to: Erukula and Chatterjee, Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns)

This article refers to:

Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns)

Erukula S, Chatterjee P. 2016. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns). Journal of Microencapsulation. http://dx.doi.org/10.1080/02652048.2016.1222006.

When the above article was first published online, Figure 2A and 2B was a duplication of Figure 3 and also Figure 4 doesn’t contain proper indication. The correct figures and labels should be:

Figure 2.

Figure 4.

This has now been corrected in the online version.

Taylor & Francis apologises for this error.